search
Back to results

Iron Deficiency Anemia in Twin Pregnancies

Primary Purpose

Anemia, Iron-Deficiency

Status
Unknown status
Phase
Phase 4
Locations
Study Type
Interventional
Intervention
Iron
Sponsored by
Shengjing Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Anemia, Iron-Deficiency

Eligibility Criteria

16 Years - 50 Years (Child, Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • Chinese
  • Pregnant women with twin pregnancies

Exclusion Criteria:

  • Single pregnancy
  • Types of anemia other than iron deficiency anemia

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Experimental

    Arm Label

    Anemia Correction Group

    Anemia uncorrected group

    Arm Description

    Continue to take the current medication orally at the current dose

    Continue to take the current medication orally at the current dose

    Outcomes

    Primary Outcome Measures

    Routine blood
    Routine blood and serum ferritin(ng/ml)were checked 2-4 weeks

    Secondary Outcome Measures

    serum ferritin
    routine blood and serum ferritin(ng/ml)were checked 2-4 weeks

    Full Information

    First Posted
    June 21, 2021
    Last Updated
    July 22, 2021
    Sponsor
    Shengjing Hospital
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT04975074
    Brief Title
    Iron Deficiency Anemia in Twin Pregnancies
    Official Title
    Prospective Study of Iron Deficiency Anemia in Twin Pregnancy
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    July 2021
    Overall Recruitment Status
    Unknown status
    Study Start Date
    July 15, 2021 (Anticipated)
    Primary Completion Date
    December 2021 (Anticipated)
    Study Completion Date
    July 2022 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Shengjing Hospital

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No

    5. Study Description

    Brief Summary
    All pregnant women with twin pregnancies were given oral iron according to the current recommended dose. Blood routine and ferritin were monitored during pregnancy to understand the therapeutic effect of oral iron on iron deficiency anemia and iron deficiency in pregnant women with twin pregnancies
    Detailed Description
    All pregnant women with twin pregnancies were given oral iron according to the current recommended dose. Blood routine and ferritin were monitored every 2-4 weeks during pregnancy to understand the therapeutic effect of oral iron on iron deficiency anemia and iron deficiency in pregnant women with twin pregnancies.After delivery, we will test the neonatal ferritin and hemoglobin status. Our aim was to investigate the effects of iron supplementation during twin pregnancy on maternal and neonatal ferritin and anemia.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Anemia, Iron-Deficiency

    7. Study Design

    Primary Purpose
    Prevention
    Study Phase
    Phase 4
    Interventional Study Model
    Sequential Assignment
    Masking
    None (Open Label)
    Allocation
    Non-Randomized
    Enrollment
    1000 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Anemia Correction Group
    Arm Type
    Experimental
    Arm Description
    Continue to take the current medication orally at the current dose
    Arm Title
    Anemia uncorrected group
    Arm Type
    Experimental
    Arm Description
    Continue to take the current medication orally at the current dose
    Intervention Type
    Drug
    Intervention Name(s)
    Iron
    Other Intervention Name(s)
    ferrous sulfate, polyferose, ferrous succinate, Chinese medicine filling iron agent
    Intervention Description
    One of each type of iron was taken orally according to the instructions and followed every two weeks
    Primary Outcome Measure Information:
    Title
    Routine blood
    Description
    Routine blood and serum ferritin(ng/ml)were checked 2-4 weeks
    Time Frame
    2-4 weeks after antenatal care
    Secondary Outcome Measure Information:
    Title
    serum ferritin
    Description
    routine blood and serum ferritin(ng/ml)were checked 2-4 weeks
    Time Frame
    2-4 weeks after antenatal care

    10. Eligibility

    Sex
    Female
    Minimum Age & Unit of Time
    16 Years
    Maximum Age & Unit of Time
    50 Years
    Accepts Healthy Volunteers
    Accepts Healthy Volunteers
    Eligibility Criteria
    Inclusion Criteria: Chinese Pregnant women with twin pregnancies Exclusion Criteria: Single pregnancy Types of anemia other than iron deficiency anemia
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Fang Xie
    Phone
    0086-457-13604210476
    Email
    gougou531@hotmail.com
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Caixia Liu
    Organizational Affiliation
    Shengjing Hospital of CMU
    Official's Role
    Study Chair

    12. IPD Sharing Statement

    Plan to Share IPD
    No

    Learn more about this trial

    Iron Deficiency Anemia in Twin Pregnancies

    We'll reach out to this number within 24 hrs